Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
β Scribed by Philip D Harvey; Herbert Meltzer; George M Simpson; Steven G Potkin; Antony Loebel; Cynthia Siu; Steven J Romano
- Book ID
- 119362068
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 217 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0920-9964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to longβacting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirtyβsix patients with schizophrenia treated with oral
## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,